EGF and acquired polycythemia vera: Many studies on PV have, therefore, focused on the use of topical non-steroid agents as pimecrolimus (Iraji et al., 2010), nicotinamide (Iraji and Banan, 2010 ▶) and epidermal growth factor (Tabrizi et al., 2007 ▶).